Source: Eur Respir J, 52 (5) 1801089; 10.1183/13993003.01089-2018
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Delia Goletti, Cecilia S. Lindestam Arlehamn, Thomas J. Scriba, Richard Anthony, Daniela Maria Cirillo, Tonino Alonzi, Claudia M. Denkinger, Frank Cobelens. Can we predict tuberculosis cure? What tools are available?. Eur Respir J, 52 (5) 1801089; 10.1183/13993003.01089-2018

Member's Comments

No comment yet.

Related content which might interest you: What do new data concerning triple therapy tell us about the risk of infection? Source: International Congress 2019 – Exploring the link between inhaled corticosteroids and respiratory infection Year: 2019 TB following targeted and biological therapy: can we predict it? Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 How can we achieve better prevention of progression to tuberculosis among contacts? Source: Eur Respir J 2013; 42: 1743-1746 Year: 2013 Cleaning agents and asthma: what does the evidence currently tell us about diagnosis and management of these cases? Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health? Year: 2018 Will clinicians keep their place in modern management of tuberculosis? Source: Eur Respir J 2001; 18: Suppl. 33, 474s Year: 2001 Is PPD still a screening diagnostic tool for tuberculosis alone, or for something else also? Source: Eur Respir J 2006; 28: Suppl. 50, 21s Year: 2006 Are in vitro sensitivity tests for tuberculosis drugs a good guide of clinical outcome? Source: Annual Congress 2006 - The management of multidrug-resistant tuberculosis (MDRTB) on an individual and national level Year: 2006 How quickly do we identify and treat patients with TB ? Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 Should we treat every patient with latent TB? Is there a cost to pay? Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 MDR-TB management: what is new? Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis Source: Eur Respir Monogr 2018; 82: 414-429 Year: 2018 Do we need bacteriological confirmation of cure in uncomplicated tuberculosis? Source: Eur Respir J 2013; 42: 860-863 Year: 2013 Conversion of tuberculosis screening tests during biological therapy in patients with rheumatic diseases: what’s beyond screening values? Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 What do they know about TB? Source: Eur Respir J 2002; 20: Suppl. 38, 163s Year: 2002 Steroids related tuberculosis: Does a subgroup require a more cautious approach? Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011 Failing a re-treatment regimen does not predict MDR/XDR tuberculosis: is “blind” treatment dangerous? Source: Eur Respir J 2011; 37: 1283-1285 Year: 2011 Which are the best methods to manage COPD patients in the post-COVID era? Source: Virtual Congress 2021 – Part I: restarting COPD care in the post-COVID era Year: 2021 What do we need in the clinic and what approach can clinicians take to improve the drug development pipeline? Source: ERS Research Seminar 2016 Year: 2016 TB disease and infection. Do we have real news? Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 Individualising treatment for tuberculosis: what has whole genome sequencing taught us so far? Source: Virtual Congress 2020 – Respiratory infections Year: 2020